Moreover, co-expression of p-CDK5/p-TRIM59, p-CDK5/p-STAT3, or p-TRIM59/p-STAT3 at high levels correlated with GBM prognosis (Fig. 9c). This evidence concerns the gene CDK5 and glioblastoma.